- Home
- ORIO vs VYNE Comparison
ORIO vs VYNE Comparison
Compare ORIO & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORIO | VYNE |
|---|---|---|
| Founded | N/A | 2003 |
| Country | Canada | United States |
| Employees | 188 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.0M | 21.6M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | ORIO | VYNE |
|---|---|---|
| Price | $0.85 | $0.65 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 33.2K | ★ 117.5K |
| Earning Date | 03-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $74.52 | N/A |
| Revenue Next Year | $5.07 | N/A |
| P/E Ratio | $4.93 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.81 | $0.29 |
| 52 Week High | $1.40 | $1.72 |
Technical Indicators
Market Signals| Indicator | ORIO | VYNE |
|---|---|---|
| Relative Strength Index (RSI) | 41.16 | 48.68 |
| Support Level | $0.84 | $0.62 |
| Resistance Level | $0.98 | $0.69 |
| Average True Range (ATR) | 0.06 | 0.03 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 25.51 | 60.45 |
Price Performance
Historical ComparisonAbout ORIO Orion Digital Corp. Common Shares
Orion Digital Corp is a financial technology company operating digital platforms across wealth and payments, supported by a consumer lending business in Canada. The Company's Wealth platform, Intelligent Investing, provides long-term investment solutions to the Canadian market. It also operates a consumer lending business in Canada. Its Payments business is conducted through its wholly owned subsidiary, which provides issuer processing, program management, and regulated payment orchestration services across Europe. The Company operates in Canada and Europe, with Canada generating the majority of its revenue.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.